Request For Proposal (RFP) for Pharmacological testing of novel stimulants, and synthetic cannabinoids.
Public summary
Generated or condensed from imported source text. Verify before bidding.
Health Canada has issued an amended, open RFP for in vitro pharmacological testing of novel synthetic cannabinoids and stimulant compounds. The work is intended to help assess the risks and pharmacological activity of emerging substances found in the illegal drug supply and support regulatory science decisions. The opportunity has two separately evaluated streams: - Stream 2: Testing novel synthetic cannabinoids. - Stream 3: Testing stimulant compounds. A bidder may submit an offer for one stream or both. Health Canada may award up to two contracts, potentially one for each stream. The required work appears to include obtaining reference standards and control samples, securing any required controlled-substance licences, conducting laboratory experiments, performing statistical analysis, and preparing and finalizing technical reports. This opportunity may be relevant to organizations with suitable pharmacology, laboratory-testing, controlled-substance compliance, statistical-analysis, and scientific-reporting capabilities.Buyer: Department of Health (Health Canada)Status: Open Closing date: November 9, 2026, at 5:00 p.m.Location: National Capital Region, Ottawa, Ontario, and Canada-wide as indicated in the notice. The provided documents include the RFP and separate statements of work for Stream 2 and Stream 3. Review the complete official tender documents for mandatory qualifications, laboratory and licensing requirements, submission instructions, evaluation criteria, contract terms, amendments, and the applicable time zone. This summary does not confirm that any business qualifies. Verify all details in the official tender notice before preparing or submitting a bid: https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/111300/english-rfp-1000273405-1a.pdf
Requirement preview
A profile unlocks the full bid checklist and match explanation.
- The procurement concerns in vitro pharmacological testing of novel synthetic cannabinoids and stimulant compounds for Health Canada.
- Bidders may submit a proposal for one stream or for both streams. Stream 2 covers in vitro pharmacological testing of novel synthetic cannabinoids; Stream 3 covers in vitro pharmacological testing of stimulant compounds.
- Each stream will be evaluated separately, and up to two contracts may be awarded.
- The work appears to require acquiring reference standards and control samples.
Source description preview
Imported source text may contain formatting from the original notice.
Amended Request For Proposal (RFP) for Pharmacological testing of stimulants, and synthetic cannabinoids. Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs increase the risk of overdose risks. Evidence on the pharmacological activity of these substances is essential to support scientific regulatory activities and risk assessments. The illegal drug supply is continuously evolving, with new substances continually being detected. There is a need for further information on their harms to Canadians. This procurement activity will allow for the evaluation of the in vitro pharmacological activity of two categories of emerging drugs: synthetic cannabinoids, and stimulants. The data generated from this contract will inform future assessment activities and allow the OLRA to make more informed regulatory science decisions. For both streams, they require the pharmacological testing of different classes of substances, and require acquisition of reference standards and control samples, getting licenses for controlled substances, conducting experiments (including doing statistical analysis), and finally drafting and finalizing reports. Canada is seeking offers from Offerors to provide Pharmacological Testing for Stimulants, and Synthetic Cannabinoids in two (2) separate streams to Health Canada. Stream 2 – In vitro pharmacological testing of novel synthetic cannabinoids and Stream 3 – In vitro pharmacological testing of stimulant compounds. Each stream will be evaluated separately, and bidders are to provide their submissions for one (1) stream or two (2) streams. Up to two (2) contracts may be awarded under this amended request for proposal.
Turn this listing into a bid decision.
Build a company profile to unlock match scoring, explanations, checklist next steps, saved opportunity tracking, and alerts.